1) Leukotriene receptor antagonist
白三烯受体拮抗剂
1.
Protective effect of ONO-1078,a leukotriene receptor antagonist,on focal cerebral ischemia induced by endothelin-1 in rats;
白三烯受体拮抗剂ONO-1078对内皮素-1诱导的大鼠局灶性脑缺血的保护作用
2.
Effect of leukotriene receptor antagonist on cough variant asthma
白三烯受体拮抗剂对咳嗽变异性哮喘的作用
3.
Objective: To investigate the influence of the leukotriene receptor antagonist (montelukast) on airway remodeling and the expression of cyclin D1 in a murine model of asthma, and to explore the role of montelukast in dealing with asthma.
目的:研究应用白三烯受体拮抗剂(孟鲁司特钠)对哮喘小鼠肺组织中细胞周期蛋白D1(CyclinD1)的表达影响及对支气管哮喘气道重塑的作用,探讨白三烯受体拮抗剂在哮喘治疗中的作用。
2) Leukotriene receptor antagonists
白三烯受体拮抗剂
1.
Application of leukotriene receptor antagonists in childhood disease
白三烯受体拮抗剂在儿科疾病中的应用现状
2.
RESULTS & CONCLUSION:Leukotriene receptor antagonists have become the most effective mediator antagonists in clinic treatment of asthma and which are currently widely used in the clinic.
目的:评价白三烯受体拮抗剂的临床应用概况。
3.
OBJECTIVE: To evaluate the efficacy and safety of leukotriene receptor antagonists (LTRAs) for exercise-induced asthma (EIA).
已有两篇Cochrane系统评价证实白三烯受体拮抗剂单独或联合吸入糖皮质激素治疗可使哮喘患者中度获益。
3) leukotrienes receptor antagonist
白三烯受体拮抗剂
1.
Effect of leukotrienes receptor antagonist on the expressional levels of matrix metalloproteinase- 9 and its inhibitor TIMP- 1 in rats with asthma;
白三烯受体拮抗剂对哮喘大鼠基质金属蛋白酶-9及其抑制剂表达的影响
2.
METHODS:The literatures about leukotrienes receptor antagonists at home and abroad were reviewed,analyzed and summarized.
目的 :评价白三烯受体拮抗剂在治疗哮喘中的进展和临床应用。
4) leukotrienes D 4 receptor antagonist
白三烯D4受体拮抗剂
5) cysteinyl leukotriene receptor antagonist
半胱氨酰白三烯受体拮抗剂
1.
Aim To determine whether pranlukast (ONO-1078), a cysteinyl leukotriene receptor antagonist, possesses therapeutic effect when administered after focal cerebral ischemia in mice.
目的 观察半胱氨酰白三烯受体拮抗剂pranlukast(ONO 10 78)在小鼠局灶性脑缺血后的治疗作用。
6) Leukotriene modifier
白三稀受体拮抗剂
补充资料：钙拮抗剂
| 钙拮抗剂 calcium antagonists 主要通过阻断心肌和血管平滑肌细胞膜上的钙离子通道，抑制细胞外钙离子内流，使细胞内钙离子水平降低而引起心血管等组织器官功能改变的药物。临床常用的有硝苯吡啶、异搏定、硫氮唑酮等。对心脏的作用，主要是抑制心肌去极化过程中第二时相钙离子内流，降低细胞内钙，减弱心肌收缩力，降低心肌氧耗量，同时抑制窦房结和房室结的钙内流，使窦房结自律性下降，房室传导减慢，心室率降低，如异搏定，硫氮唑酮。在血管主要扩张动脉平滑肌，降低外周阻力，而对静脉平滑肌作用甚小，如硝苯吡啶。此类药物临床主要应用于高血压病、冠心病和心律失常。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条